Imprimis inks licence agreement with Urigen for patented ...
pharmabiz.com › News
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, October 31, 2014
Imprimis inks licence agreement with Urigen for patented compound formulation
Notice from Texas Board of Pharmacy Regarding New Rules
Rules adopted at the August 2014 Board meeting were published as adopted in the September 5, 2014, issue of the Texas Register and became effective September 11, 2014. Rules proposed at the February Board meeting were posted in the September 26, 2014, issues of the TexasRegister. The proposed rules will be considered for adoption at the next TSBP board meeting on November 4, 2014. You may view a summary of the adopted and proposed rules here. Please note underlined language is new language and language that is being deleted is lined out. All other language is currently in the rules and is not being changed.
Subscribe to:
Posts (Atom)